Physician profile
Aaron L Rupp
NPI 1689950883
$3,979.42
in general payments reported to CMS, 2019-2025
22 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $1,596 · 2021: $13.56 · 2022: $313 · 2023: $302 · 2024: $304 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $1,653.53 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $863.05 | 2019-2024 | Nancy Nail |
| Stryker Corporation | $391.68 | 2022-2025 | Blueprint Patient Specific Instrumentation, Procinch, Inspace |
| Smith+Nephew, INC. | $218.65 | 2019-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Novostitch |
| Depuy Synthes Sales INC. | $127.87 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Ferring Pharmaceuticals INC. | $119.79 | 2019-2023 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $106.02 | 2019-2025 | Iovera, Exparel, Zilretta |
| Amgen INC. | $95.77 | 2023-2025 | Evenity, Prolia |
| Bioventus LLC | $61.08 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $54.52 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $51.60 | 2024-2025 | |
| Radius Health, INC. | $39.75 | 2025 | Tymlos |
| Skeletal Dynamics INC | $30.00 | 2020 | |
| Acumed LLC | $29.46 | 2025 | Acumed |
| Linvatec Corporation | $27.77 | 2025 | Shoulder Cannulas, Biobrace 23mm |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $22.63 | 2023 | Krystexxa |
| Kerecis Limited | $18.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Boston Scientific Corporation | $17.11 | 2020 | |
| Heraeus Medical, LLC. | $15.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.35 | 2022 | |
| Pacira Therapeutics, INC. | $11.48 | 2019 | |
| Ermi LLC | $10.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Rupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.